Real-world evidence submissions increasingly depend on patient registries that span dozens of hospitals, specialty clinics, and academic...
real-world evidence
The conversation around patient-generated wearable data in regulatory submissions has shifted from speculative to operational. Sponsors no...
Using registry data to produce real-world evidence (RWE) is widely recognized as a powerful complement to randomized...
For most digital therapeutics (DTx) companies, the phrase “DTx reimbursement: using RWE to satisfy CMS in 90...
As digital therapeutics (DTx) expand into chronic disease management, the pressure to generate compelling evidence for payer...
For digital therapeutic (DTx) startups, the question is no longer whether real-world evidence matters, but how to...
The phrase synthetic control arms in regulatory filings once belonged to statistically minded insiders discussing methodological curiosities....
Payer negotiation tactics with real-world registry data are now central to winning coverage for medical devices, diagnostics,...
There is no clean line in the sand when it comes to FDA’s acceptance of real-world evidence...